$3.13 Billion is the total value of ALTRINSIC GLOBAL ADVISORS LLC's 170 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPNE | SEASPINE HLDGS CORP | $7,522,000 | -13.4% | 552,274 | 0.0% | 0.24% | -7.7% | |
| CI | CIGNA CORP NEW | $5,350,000 | +14.7% | 23,300 | 0.0% | 0.17% | +22.1% | |
| XENE | XENON PHARMACEUTICALS INC | $5,311,000 | +104.4% | 170,000 | 0.0% | 0.17% | +116.7% | |
| ANTM | ANTHEM INC | $4,682,000 | +24.4% | 10,100 | 0.0% | 0.15% | +31.9% | |
| ITCI | Intra-Cellular Therapies Inc. | $4,187,000 | +40.4% | 80,000 | 0.0% | 0.13% | +50.6% | |
| MORF | MORPHIC HLDG INC | $3,245,000 | -16.3% | 68,485 | 0.0% | 0.10% | -10.3% | |
| GILD | GILEAD SCIENCES INC | $3,267,000 | +3.9% | 45,000 | 0.0% | 0.10% | +10.6% | |
| LNTH | LANTHEUS HLDGS INC | $3,178,000 | +12.5% | 110,000 | 0.0% | 0.10% | +18.8% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $2,750,000 | +9.7% | 168,800 | 0.0% | 0.09% | +17.3% | |
| JAZZ | Jazz Pharmaceutical plc | $2,675,000 | -2.2% | 21,000 | 0.0% | 0.08% | +3.7% | |
| PRQR | PROQR THRAPEUTICS N V | $2,574,000 | -4.3% | 321,360 | 0.0% | 0.08% | +1.2% | |
| BKD | BROOKDALE SR LIVING INC | $2,283,000 | -18.1% | 442,452 | 0.0% | 0.07% | -13.1% | |
| NVST | Envista Holdings Corp | $2,253,000 | +7.7% | 50,000 | 0.0% | 0.07% | +14.3% | |
| AERI | AERIE PHARMACEUTICALS INC | $1,895,000 | -38.4% | 270,000 | 0.0% | 0.06% | -34.8% | |
| KZR | Kezar Life Sciences Inc | $1,672,000 | +93.5% | 100,000 | 0.0% | 0.05% | +103.8% | |
| SGMO | SANGAMO THERAPEUTICS INC | $1,624,000 | -16.8% | 216,500 | 0.0% | 0.05% | -10.3% | |
| FATE | Fate Therapeutics Inc. | $1,580,000 | -1.2% | 27,000 | 0.0% | 0.05% | +4.2% | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $1,576,000 | -12.0% | 100,000 | 0.0% | 0.05% | -7.4% | |
| KURA | Kura Oncology Inc. | $1,540,000 | -25.2% | 110,000 | 0.0% | 0.05% | -21.0% | |
| MGNX | MACROGENICS INC | $1,124,000 | -23.3% | 70,000 | 0.0% | 0.04% | -18.2% | |
| AGTC | Applied Genetic Technologies Corp. | $716,000 | -36.9% | 376,900 | 0.0% | 0.02% | -32.4% | |
| CTMX | Cytomx Therapeutics Inc. | $520,000 | -14.9% | 120,000 | 0.0% | 0.02% | -5.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KINROSS GOLD CORP | 42 | Q3 2023 | 5.5% |
| BP PLC | 42 | Q3 2023 | 6.3% |
| COMCAST CORP NEW | 42 | Q3 2023 | 3.0% |
| PUBLIC SVC ENTERPRISE GRP IN | 42 | Q3 2023 | 2.7% |
| CISCO SYS INC | 42 | Q3 2023 | 2.4% |
| ORACLE CORP | 40 | Q1 2023 | 2.1% |
| VODAFONE GROUP PLC NEW | 39 | Q3 2023 | 7.5% |
| INTERCONTINENTAL EXCHANGE INC. | 37 | Q3 2023 | 4.5% |
| PEPSICO INC | 37 | Q2 2022 | 3.0% |
| EOG RES INC | 36 | Q3 2023 | 1.5% |
View ALTRINSIC GLOBAL ADVISORS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Diversicare Healthcare Services, Inc.Sold out | February 10, 2022 | 0 | 0.0% |
| AAC Holdings, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| trivago N.V.Sold out | February 13, 2019 | 0 | 0.0% |
| TearLab CorpSold out | February 14, 2018 | 0 | 0.0% |
| FOSTER WHEELER AG | February 13, 2014 | 1,488,236 | 1.5% |
| COOPER COMPANIES INC | February 08, 2010 | 71,500 | 0.1% |
| ADVOCAT INC | January 14, 2010 | 443,952 | 8.0% |
View ALTRINSIC GLOBAL ADVISORS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-10 |
View ALTRINSIC GLOBAL ADVISORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.